Cytokine and chemokine profiling shows rapid activation of the immune system following enzyme replacement therapy in Pompe disease
Elisa Masat(Inserm), Federico Mingozzi(Spark Therapeutics (United States)), Pascal Laforêt(Assistance Publique – Hôpitaux de Paris), P. Véron(Genethon (France)), Barbara Perniconi(Sorbonne Université), Damien Amelin(Inserm), Nadjib Taouagh(Sorbonne Université), Olivier Benvéniste(Inserm)
Cited by 0
Related Papers
Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles
|The Journal of Immunology|2001|1.5k
Mutations in dynamin 2 cause dominant centronuclear myopathy
|Nature Genetics|2005|462
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
|Science Translational Medicine|2013|346
Multiple Phenotypes in Phosphoglucomutase 1 Deficiency
|New England Journal of Medicine|2014|287
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
|Journal of Clinical Investigation|2013|232